Corporate DoubleRainbow Biosciences Announces Strategic AI Collaboration with Galixir Press Release 7 Nov 2022
Research & Development Double Rainbow ramps up production of ancient natural painkiller Read on NutraIngredients USA 7 Dec 2022
Corporate Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic with a Range of Therapeutic Applications Press Release 28 Nov 2022
Research & Development Kelai pens Double Rainbow pact to pair drug delivery and biosynthesis tech Read on Fierce Pharma 24 Aug 2022
Corporate DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeutics Press Release 22 Aug 2022
Sustainability Cutting the carbon footprint of pharma’s supply chain Read on Pharmaceutical Technology 9 Feb 2022
Sustainability Pharma Sets a Foundation for Greener API Manufacturing Read on Pharmaceutical Technology 23 Dec 2021
Drug Discovery Is Poor Bioavailability Holding Back Modern Medicine? By Jing-Ke Weng, PhD 23 Dec 2021